These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24261031)

  • 61. Is there a risk for lymphoma or extracolonic cancer in patients with inflammatory bowel disease?
    Toader E; Ciortescu I
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):368-74. PubMed ID: 24340518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis.
    Ozturk NB; Fiel MI; Schiano TD
    JGH Open; 2022 Sep; 6(9):607-611. PubMed ID: 36091322
    [TBL] [Abstract][Full Text] [Related]  

  • 63. General principles of medical therapy of inflammatory bowel disease.
    Friedman S
    Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: 'a cocktail best avoided, not stirred'.
    van Langenberg DR; Morrison G; Foley A; Buttigieg RJ; Gibson PR
    J Crohns Colitis; 2011 Oct; 5(5):469-72. PubMed ID: 21939923
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Liver complications in inflammatory bowel diseases.
    Wieser V; Gerner R; Moschen AR; Tilg H
    Dig Dis; 2013; 31(2):233-8. PubMed ID: 24030232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation.
    Gerlag PG; Lobatto S; Driessen WM; Deckers PF; Van Hooff JP; Schröder E; Assmann KM; Van Haelst UJ
    J Hepatol; 1985; 1(4):339-48. PubMed ID: 3902952
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Idiopathic non-cirrhotic portal hypertension (INCPH) during azathioprine treatment in patient with Crohn's disease: A case report.
    Chabbouh K; Cherif D; Debbabi H; Kchir H; Hassine H; Ben-Hammamia S; Lakhoua G; Jarray A; Frikha W; Chelly B; El-Aidli S; Mizouni H; Haouet S; Maamouri N
    Therapie; 2022; 77(4):489-491. PubMed ID: 34454746
    [No Abstract]   [Full Text] [Related]  

  • 68. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients.
    Dubinsky MC; Vasiliauskas EA; Singh H; Abreu MT; Papadakis KA; Tran T; Martin P; Vierling JM; Geller SA; Targan SR; Poordad FF
    Gastroenterology; 2003 Aug; 125(2):298-303. PubMed ID: 12891528
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Awareness of adverse effects of azathioprine in patients with inflammatory bowel disease--more to be done?
    Spence AD; Lee R; Keegan D; Doherty GA; Mulcahy H; Murphy S
    Ulster Med J; 2014 Jan; 83(1):56-7. PubMed ID: 24757277
    [No Abstract]   [Full Text] [Related]  

  • 70. Are we giving azathioprine too much time?
    Gomollón F; García López S
    World J Gastroenterol; 2008 Sep; 14(36):5519-22. PubMed ID: 18810769
    [TBL] [Abstract][Full Text] [Related]  

  • 71. IBD: incidence of HSV and HPV with azathioprine.
    Cottone M; Renna S
    Nat Rev Gastroenterol Hepatol; 2009 Aug; 6(8):444-5. PubMed ID: 19654597
    [No Abstract]   [Full Text] [Related]  

  • 72. Suspected azathioprine induced liver cirrhosis: an unusual side effect.
    Trabelsi AB; Hamami E; Souguir A; Ksiaa M; Ajmi S; Jmaa A
    Pan Afr Med J; 2014; 17():174. PubMed ID: 25392720
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Azathioprine-induced acute pancreatitis in inflammatory bowel disease : natural history and severity spectrum.
    Peixoto A; Pinto ER; Silva M; Coelho R; Santos-Antunes J; Andrade P; Gaspar R; Nunes A; Lopes S; Macedo G
    Acta Gastroenterol Belg; 2017; 80(1):87-88. PubMed ID: 29364109
    [No Abstract]   [Full Text] [Related]  

  • 74. Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis.
    Mion F; Napoleon B; Berger F; Chevallier M; Bonvoisin S; Descos L
    Gut; 1991 Jun; 32(6):715-7. PubMed ID: 2060883
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Infectious mononucleosis in patients with inflammatory bowel disease under treatment with azathioprine].
    Bargalló A; Carrión S; Domènech E; Arévalo JA; Mañosa M; Cabré E; Cabriada JL; Gassull MA
    Gastroenterol Hepatol; 2008 May; 31(5):289-92. PubMed ID: 18448058
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Indications for azathioprine treatment in inflammatory bowel disease].
    Cabré E
    Gastroenterol Hepatol; 2002 May; 25(5):319-26. PubMed ID: 11985804
    [No Abstract]   [Full Text] [Related]  

  • 77. Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation.
    Nataf C; Feldmann G; Lebrec D; Degott C; Descamps JM; Rueff B; Benhamou JP
    Gut; 1979 Jun; 20(6):531-7. PubMed ID: 381128
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nodular regenerative hyperplasia of the liver graft after liver transplantation.
    Gane E; Portmann B; Saxena R; Wong P; Ramage J; Williams R
    Hepatology; 1994 Jul; 20(1 Pt 1):88-94. PubMed ID: 8020909
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Methotrexate or azathioprine-do differing rates of discontinuation settle the debate?
    Fraser AG
    Aliment Pharmacol Ther; 2020 Nov; 52(9):1527-1528. PubMed ID: 33263378
    [No Abstract]   [Full Text] [Related]  

  • 80. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy.
    Read AE; Wiesner RH; LaBrecque DR; Tifft JG; Mullen KD; Sheer RL; Petrelli M; Ricanati ES; McCullough AJ
    Ann Intern Med; 1986 May; 104(5):651-5. PubMed ID: 3008617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.